SEARCH

SEARCH BY CITATION

References

  • BAKKER, M.H. & FOSTER A.C. (1991). An investigation of the mechanisms of delayed neurodegeneration caused by direct injection of quinolinate into the rat striatum in vivo. Neuroscience, 42, 387395.
  • BEDERSON, J., PITTS, L., TSUJI, M., NISHIMURA, M., DAVIS, R. & BARTKOWSKI, H. (1986). Rat middle cerebral artery occlusion: evaluation of the model and development of a neurological examination. Stroke, 17, 472476.
  • BELAYEV, L., BUSTO, R., IKEDA, M., RUBIN, L.L., KAJIWARA, A., MORGAN, L. & GINSBERG, M.D. (1998). Protection against blood-brain barrier disruption in focal cerebral ischemia by the type IV phosphodiesterase inhibitor BBB022: a quantitative study. Brain Res., 787, 277285.
  • BETZ, A.L. (1996). Alterations in cerebral endothelial cell function in ischemia. Adv. Neurol., 71, 301313.
  • BRINKER, G., FRANKE, C., HOEHN, M., UHLENKUKEN, U. & HOSSMANN, K.A. (1999). Thrombolysis of cerebral clot embolism in rat: effect of treatment delay. Neuroreport, 10, 32693272.
  • BUSTO, R., DIETRICH, W.D., GLOBUS, M.Y., VALDOS, A., STEINBERG, P. & GINSBERG, W.D. (1987). Small differences in intraischemic brain temperature critically determine the extent of ischemic brain injury. J. Cereb. Blood Flow Metab., 7, 729738.
  • CARCIA, J.H., LUI, K.F. & RELTON, J.K. (1995). Interleukin-1 receptor antagonist decreases the number of necrotic neurons in rats with middle cerebral artery occlusion. Am. J. Pathol., 146, 14771486.
  • CAO, X. & PHILLIS, J. (1994). α-Phenyl-tert-butyl-nitrone reduces cortical infarct and edema in rats subjected to focal ischemia. Brain Res., 644, 267272.
  • CLARK, W.M., MADDEN, K.P., ROTHLEIN, R. & ZIVIN, J.A. (1991). Reduction of central nervous system ischemic injury by monoclonal antibody to intracellular adhesion molecule. J. Neurosurg., 75, 623627.
  • CORBETT, D., EVANS, S., THOMAS, L., WANG, D. & JONAS, R. (1990). MK 801 reduces cerebral ischemic injury by inducing hypothermia. Brain Res., 514, 300304.
  • DOWDEN, J., REID, C., DOOLEY, P & CORBETT, D. (1999). Diazepam-induced neuroprotection: dissociating the effects of hypothermia following global ischemia. Brain Res., 829, 16.
  • FACCHINETTI, F., DAWSON, V.L. & DAWSON, T.M. (1998). Free radicals as mediators of neuronal injury. Cell. Mol. Neurobiol., 18, 667682.
  • FOSTER, A.C., GILL, R. & WOODRUFF, G.N. (1988). Neuroprotective effects of MK-801 in vivo: Selectivity and evidence for delayed degeneration mediated by NMDA receptor activation. J. Neurosci., 8, 47454754.
  • HALLENBECK, J.M. (1996). Inflammatory reactions at the blood-endothelial interface in acute stroke. Adv. Neurol., 71, 281300.
  • KATO, H., KOGURE, K., LUI, X.H., ARAKI, T. & ITOYAMA, Y. (1996). Progressive expression of immunomolecules on activated microglia and invading leukocytes following focal ischemia in the rat. Brain Res., 734, 203212.
  • KURODA, S., KATSURA, K., HILLERED, L., BATES, T.E. & SIESJÖ, B.K. (1996). Delayed treatment with α-phenyl-N-tert-butyl nitrone (PBN) attenuates secondary mitochondrial dysfunction after transient focal cerebral ischemia in the rat. Neurobiol. Dis., 3, 149157.
  • KURODA, S., TSUCHIDATE, R., SMITH, M-L., MAPLES, K.R. & SIESJÖ, B.K. (1999). Neuroprotective effects of a novel nitrone, NXY-059, after transient focal ischemia in the rat. J. Cereb. Blood Flow Metab., 19, 778787.
  • LEES, K.R., SHARMA, A.K. BARER, D., FORD, G.A. KOSTULAS, V., CHENG, Y.F. & ODERGREN, T. (2001). Tolerability and pharmacokinetics of the nitrone NXY-059 in patients with acute stroke. Stroke, 32, 675680.
  • LEINONEN, J.S., AHONEN, J.P., LONNROT, K., JEHKONEN, M., DASTIDAR, P., MOLNAR, G. & ALHO, H. (2000). Low plasma antioxidant activity is associated with high lesion volume and neurological impairment in stroke. Stroke, 31, 3339.
  • MARSHALL, J.W.B., DUFFIN, K.J., GREEN, A.R. & RIDLEY, R.M. (2001). NXY-059, a free radical trapping agent, substantially lessens the functional disability resulting from cerebral ischemia in a primate species. Stroke, 32, 190198.
  • MASSIEU, L., THEDINGA, K.H., MCVEY, M. & FAGG, G.E. (1993). A comparative analysis of the neuroprotective properties of competitive and uncompetitive N-methyl-D-aspartate receptor antagonists in vivo: Implications for the process of excitotoxic degeneration and its therapy. Neuroscience., 55, 883892.
  • MOHR, J.P., GAUTIER, J.C., HIER, D., & STEIN, R.W. (1986). Middle cerebral artery. In Stroke: Pathophysiology, Diagnosis and Management. eds Barnett HJM, Stein BM, Mohr JP Yatsu FM. Vol.1, pp 377450, New York: Churchill Livingstone.
  • NURSE, S. & CORBETT, D. (1996). Neuroprotection after several days of mild drug-induced hypothermia. J. Cereb. Blood Flow Metab., 16, 474480.
  • OLIVER, C., STARKE-REED, P., STADTMAN, E., LUI, G., CARNEY, J.M. & FLOYD, R.A. (1990). Oxidative damage to brain proteins, loss of glutamine synthetase activity, and production of free radicals during ischemia/reperfusion-induced injury to gerbil brain. Proc. Natl. Acad. Sci. U.S.A., 87, 51445147.
  • PAXINOS, G. & WATSON, C. (1986). The rat brain in stereotaxic co-ordinates: 2nd edn, London: Academic Press.
  • PEELING, J., DEL BIGIO, M.R., CORBETT, D., GREEN, A.R. & JACKSON, D.M. (2001). Efficacy of disodium 4-[(tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide NXY-059), a free radical trapping agent, in a rat model of hemorrhagic stroke. Neuropharmacology, 40, 433439.
  • PHILLIS, J. & CLOUGH-HELFMAN, C. (1990). Protection from cerebral ischemia injury in gerbils with the spin trap agent N-tert-butyl-α-phenylnitrone (PBN). Neurosci. Letts., 116, 315319.
  • RELTON, J.K. & ROTHWELL, N.J. (1996). Interleukin-1 receptor antagonist inhibits ischemic and excitotoxic neuronal damage in the rat. Brain Res. Bull., 29, 243246.
  • RINGELSTEIN, E.B., BINIEK, R., WEILLER, C., AMMELING, B., NOLTE, P.N. & THRON, A. (1992). Type and extent of hemispheric brain infarctions and clinical outcome in early and delayed middle cerebral artery recanalization. Neurology, 42, 289298.
  • SCHULZ, J.B., HENSHAW, D.R., SIWEK, D., JENKINS, B.G., FERRANTE, R.H., CIPOLONI, P.B., KOWALL, N.W., ROSEN, B.R. & BEAL, M.F. (1995a). Involvement of free radicals in excitotoxicity in vivo. J. Neurochem., 64, 22392247.
  • SCHULZ, J.B., MATHEWS, R.T., JENKINS, B.G., BRAR, P. & BEAL, M.F. (1995b). Improved therapeutic window for treatment of histotoxic hypoxia with a free radical spin trap. J. Cereb. Blood Flow Metab., 15, 948952.
  • SYDSERFF, S.G., CROSS, A.J., WEST, K.J. & GREEN, A.R. (1995). The effect of chlormethiazole on neuronal damage in a model of transient focal ischaemia. Br. J. Pharmacol., 114, 16311635.
  • TASDEMIROGLU, E., CHRISTENBERRY, P.D., ARDELL, J.L., CHRONISTER, R.B. & TAYLOR, A.E. (1994). Effects of antioxidants on the blood-brain barrier and postischemic hyperemia. Acta Neurochir., 131, 302309.
  • THE NINDS T-PA STROKE STUDY GROUP (1995). Tissue plasminogen activator for acute ischemic stroke. New Engl. J. Med., 333, 15811587.
  • THE NINDS T-PA STROKE STUDY GROUP (1997). Generalized efficacy of t-PA for acute stroke. Subgroup analysis of the NINDS t-PA Stroke Trial. Stroke, 28, 21192125.
  • THE NINDS T-PA STROKE STUDY GROUP (1999). Effects of tissue plasminogen activator for acute ischemic stroke at one year. New Engl. J. Med., 340, 17811787.
  • YANG, Y., LI, Q. & SHUAIB, A. (2000). Neuroprotection by 2-h postischemia administration of two free radical scavengers, alpha-phenyl-n-tert-butyl-nitrone (PBN) and N-tert-butyl-(2-sulfophenyl)-nitrone (S-PBN), in rats subjected to focal embolic cerebral ischemia. Exp. Neurol., 163, 3945.
  • ZHANG, R.L., CHOPP, M. & JIANG, N. (1995). Anti-intercellular adhesion molecule-1 antibody reduces ischemic cell damage after transient but not permanent middle cerebral artery occlusion in the Wistar rat. Stroke, 26, 14381443.
  • ZHAO, Q., PAHLMARK, K., SMITH, M.L. & SIESJÖ BK (1994). Delayed treatment with the spin trap α-phenyl-tert-butyl-nitrone (PBN) reduces infarct size following transient middle cerebral artery occlusion in rats. Acta Physiol. Scand., 152, 349350.
  • ZHAO, A., CHENG, M., MAPLES, K.R., MA, J.Y. & BUCHAN, A.M. (2001). NXY-059, a novel free radical trapping compound, reduces cortical infarction after permanent focal cerebral ischemia in the rat. Brain Res., 909, 4650.